BERGENBIO LIMITEDActive

Company number 10555293Private limited companyIncorporated 2017

Key figures

−£91-100.1%
Net assets 2025
-400 k-200 k0200 k20202021202220232025

Like most small UK companies, BERGENBIO LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m20202021202220232025
Filed accounts2020–2025
20202021202220232025
Turnover48,077,425————
Cash at bank and in hand479,107719,2211,057,066501,19915,709
Total assets8,199,5561,174,7601,863,777981,47920,504
Total liabilities8,519,2721,127,9581,899,321879,24920,595
Net assets / total equity-319,71646,802-35,544102,230-91
Average number of employees183026175
Average pay (per year)1,492,816————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The company is involved in research and development in the biotechnology sector.

As described in the company's latest filed accounts.

Summary: BERGENBIO LIMITED

Company

BERGENBIO LIMITED is a private limited company registered with Companies House under company number 10555293. It was incorporated on 10 Jan 2017. Its status is active. The registered office is in Oxford (OX1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were −£91, down 100.1% on the previous year. Cash at bank and in hand was £15,709. Total assets were £20,504 and total liabilities £20,595. The company had an average of 5 employees. Figures are available for 5 financial years (2020–2025).

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 23 Jan 2027.